Sage Therapeutics said Wednesday that its experimental anti-depression pill alleviated symptoms within three days of treatment, achieving the goal of a clinical trial involving patients with major depressive disorder.
The rapid antidepressant effect of the Sage drug, called zuranolone, is a novel feature that differentiates it from currently available drugs that are slower acting and might be taken for months, if not longer, Sage said.
About the Author Reprints
Create a display name to comment
This name will appear with your comment
